SOROS FUND Management LLC, 10% Owner at MAP Pharmaceuticals, Inc. (MAPP), sold 101,571 shares at $14.61 ($1.5M) on 2010-03-08, disclosed to the SEC on 2010-03-10.
Open-market sale of $1.5M MAPP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.61 | 3,155 | $46K | 3.1% |
| 2 | $14.61 | 81,416 | $1.2M | 79.4% |
| 3 | $15.40 | 634 | $10K | 0.7% |
| 4 | $15.40 | 16,366 | $252K | 16.8% |
| Total | $14.74 avg | 101,571 | $1.5M | 100% |
| Filing → |
| SIGM | BUY | 2017-07-11 | $499K | — | Filing → |
| SIGM | BUY | 2017-07-06 | $2.8M | — | Filing → |
| SIGM | BUY | 2017-06-30 | $960K | — | Filing → |